Publication | Open Access
A novel NF-κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates inflammatory colonic injury in mice
62
Citations
37
References
2011
Year
DHMEQ ameliorated experimental colitis in mice. These results indicate that DHMEQ appears to be an attractive therapeutic agent for IBD.
| Year | Citations | |
|---|---|---|
Page 1
Page 1